Liver Insufficiency
8
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
Liver Function After Intravenous Methylprednisolone Administration
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)
Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment
Quantification of Drugs and Their Degradation Products
Hepatocyte Matrix Implant Study Indonesia
Liver Transplantation and Reticuloendothelial Clearance Capacity